Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $6.05 USD
Change Today -0.04 / -0.66%
Volume 4.8M
EXEL On Other Exchanges
Symbol
Exchange
Frankfurt
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Alan M. Garber M.D., Ph.D.

Director and Chairman of Nominating & Corporate Governance Committee,Exelixis, Inc.
AgeTotal Calculated CompensationThis person is connected to 53 board members in 4 different organizations across 4 different industries.

See Board Relationships
59$149,762

Background*

Dr. Alan M. Garber, M.D., Ph.D., is the Founding Director of both the university's Center for Health Policy and the Center for Primary Care and Outcomes Research at the School of Medicine. Dr. Garber is the Henry J. Kaiser Jr. Professor and a Professor of Medicine at Stanford University, where he is also Professor of Economics, Professor of Health Research and Policy, and Professor of Economics in the Graduate School of Business (courtesy). He is a Staff Physician at ...

Read Full Background

Corporate Headquarters*

210 East Grand Avenue
South San Francisco, California 94080

United States

Phone: 650-837-7000
Fax: 650-837-8300

Board Members Memberships*

Director
2005-Present
Director and Chairman of Nominating & Corporate Governance Committee

Education*

PhD
Harvard University
Unknown/Other Education
Harvard College
BA
Harvard College
MD
Stanford University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$41,500
Total Calculated Compensation$149,762
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EXEL:US $6.05 USD -0.04

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Harvey J. Berger M.D.Principal Founder, Chairman, Chief Executive Officer and President
Ariad Pharmaceuticals Inc.
$1.4M
Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma Inc.
$548.8K
Ali Fattaey Ph.D.Chief Executive Officer, President and Director
Curis, Inc.
$464.2K
Robert I. Blum Chief Executive Officer, President, Director and Chief Executive of the Biopharmaceutical Concern
Cytokinetics, Incorporated
$555.0K
Werner Lanthaler MBA,MPAChief Executive Officer and Member of Management Board
Evotec AG
€459.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EXELIXIS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.